Yangxinshi tablets for better exercise in heart disease
Part of Heart & circulation clinical trials.
This study tests if Yangxinshi tablets can help people with chronic coronary syndrome (a type of heart disease) walk farther or exercise longer. It's for those whose heart condition limits their daily activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have chronic coronary syndrome (stable heart disease) confirmed by an imaging test showing at least one narrowed artery.
- Your exercise ability is moderately or severely limited—for example, you can walk less than 450 meters in 6 minutes.
- You are willing to take part and sign a consent form.
- You are not pregnant, breastfeeding, or planning pregnancy, and you do not have serious other diseases or cancer that shorten life expectancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called selatogrel in people with chronic coronary syndrome (long-term heart disease caused by narrowed heart arteries). Researchers want to see how the body processes this drug and whether it helps prevent future heart problems.
This trial tests whether Yangxinshi tablets can help people with coronary heart disease and some degree of heart failure. It looks at improving heart function and safety over the treatment period.
This trial tests whether a Chinese herbal tablet called Jia Shen can improve heart function and reduce symptoms in people with chronic heart failure caused by coronary heart disease. It aims to find a new option that may help you feel better and stay out of the hospital.
This trial tests whether Xuesaitong soft capsules can improve major risk factors in people with stable coronary heart disease who are already on cholesterol-lowering and antiplatelet medications. You may be able to join if you have chronic coronary artery disease and certain signs of inflammation.
This trial tests whether traditional Chinese medicine can help elderly patients with coronary heart disease who still have chest pain or discomfort despite standard treatments. It focuses on those who cannot have or have not fully benefited from procedures like stents or bypass surgery.
This trial tests whether Qishen Yiqi Dripping Pills, a Chinese herbal medicine, can help people with chronic heart failure caused by coronary heart disease. It is for adults who have been on stable heart failure treatment for at least two weeks.
Hear when a new Chronic Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.